I am a Master's level biostatistician with 15 years of experience in clinical research management. The nexus of health, justice, and impact is the ethos for the work I choose.
From 2009-2020 I managed NIH-funded HIV clinical trials for the San Francisco Department of Public Health and the University of California, San Francisco in the U.S., South America, and Africa. I supported trials which led to FDA approval of multiple HIV pre-exposure prophylaxis products, and the adoption of clinical practice guidelines for HIV self-testing devices in Africa. I also consulted in the fields of reproductive health, substance use harm reduction, and qualitative and cost-effectiveness research.
From 2020-2023, I built out and oversaw Lykos Therapeutics' Investigator-Initiated Trials program, responsible for the portfolio's strategy and process. After managing the program for 3 years I transitioned to Medical Affairs as a Medical Science Liaison, among the first to hold the title in the psychedelic industry. I led field medical engagement and key stakeholder relationships in 15 states.
I have contributed to the lifecycle of over 60 clinical trials and am a co/author on 30+ publications and talks, and have a network of a few hundred CNS/Mental Health KOLs & HCPs in the US and beyond.More...